Find your next paid study

Anna Stanhewicz, PhDNCT06547619

~$500 – $11,250

Actual pay is set by the research site.

Phase 3

A Phase III Open-label, Randomised, Multicentre Study Comparing AZD0120, a Dual-Targeting Autologous Chimeric Antigen Receptor T-cell (CART) Therapy Directed Against BCMA and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma.

This is a randomised, multicentre, controlled, open-label, Phase III global study comparing the efficacy and safety of AZD0120 versus standard regimens (DKd \[…

Relapsed Refractory Multiple Myeloma

Biliary Tract CancerCholangiocarcinoma

~$50 – $2,250

Actual pay is set by the research site.

AstraZenecaNCT07391657

Phase 1

A Pilot Study of Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer

This study is being done to see if the investigators can improve the outcome of patients with biliary tract cancer that do not qualify for surgery. This study …

University of Maryland, BaltimoreNCT06546969

~$150 – $3,000

Actual pay is set by the research site.

Metabolic Dysfunction-associated Steatotic Liver Disease

Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Primary Care

This proposal evaluates the implementation of a novel, non-interruptive, electronic health record alert for metabolic dysfunction-associated steatotic liver di…

Medical University of South CarolinaNCT07159386

Actual pay is set by the research site.

Improving Psychological and Vestibular Health Using a Novel Intervention: The Making Informed Decisions in Gaze and Postural Stability (MINDGAPS) System

The purpose of this study is twofold: 1) Develop norms for measures of inner ear function and psychological health, and 2) Examine the feasibility of using the…

Vestibular Hypofunction

University of MontanaNCT05986279

Actual pay is set by the research site.

Developing and Testing Health Warning Labels on the ENDS Device

In this project, after systematically developing electronic nicotine delivery systems (ENDS) pictorial health warning labels (HWLs), a proven clinical lab mode…

Electronic Cigarette Use

Florida International UniversityNCT04907136

Actual pay is set by the research site.

EpilepsyRefractory EpilepsyMusic

SONATA: Self-administered ONe-of-a Kind Approach to Epilepsy Therapy Through a Web-based Music Application

This is a prospective, placebo-controlled, double-blinded randomized study of self-administered auditory intervention in a naturalistic home environment.

Dartmouth-Hitchcock Medical CenterNCT06425029

Actual pay is set by the research site.

Meibomian Gland Dysfunction (Disorder)

TearCare in Young Adults

This study is a non-randomized, open-label, interventional trial of TearCare® eyelid warming and manual meibomian gland expression in young adults with clinica…

University of Alabama at BirminghamNCT07579156

Actual pay is set by the research site.

Autism Spectrum DisorderAutismASD

Global Strategies, Local Impact: Testing Scalable Caregiver Interventions for Autism in Low-Resource Health Systems

Autism spectrum disorder affects 1-2% of children worldwide, yet access to quality care remains limited, especially in underserved communities. Families face s…

Indiana UniversityNCT07259044

Actual pay is set by the research site.

Phase 1

The Impact of Early ADL Participation on Functional Outcomes Post Distal Radius Fracture

This study is a randomized controlled trial (RCT). This RCT which will study the effect of performing daily activities early after a distal radius fracture bei…

Distal Radius Fracture

George Washington UniversityNCT05650996

~$500 – $7,500

Actual pay is set by the research site.

Phase 1

A Phase Ic, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, and Activity of Inhaled GDC-6988 in Patients With Muco-obstructive Disease

This study evaluates the safety, tolerability, and activity of inhaled GDC-6988 in participants with muco-obstructive disease.

Non-cystic Fibrosis BronchiectasisChronic Obstructive Pulmonary Disease

Genentech, Inc.NCT06603246

~$150 – $4,200

Actual pay is set by the research site.

Phase 2

A Phase II Trial of Trifluridine/Tipiracil Plus Oxaliplatin in Patients With Advanced or Metastatic Biliary Tract Cancer Following First-Line Therapy

Participants are eligible for this study who were treated for advanced biliary tract cancer (BTC) but the treatment either did not make the cancer better or is…

Biliary Tract CancerBiliary Tract NeoplasmsCholangiocarcinoma+2 more